Research And Development

SHANGHAI – – October 29, 2026 -- United Imaging Healthcare (688271.SH) reported revenue of RMB 10.58 billion for the first nine months of 2026, up 19.43% year-on-year, as overseas sales climbed 50.30% to RMB 3.00 billion.

R&D spending reaches 21.08% of revenue

The company invested RMB 2.23 billion in R&D over the nine months, equal to 21.08% of revenue and 0.14 percentage points higher than a year earlier. It employs 3,937 R&D staff. Cumulative R&D investment from 2022, the year of its public listing, through September 2026 totals RMB 10.50 billion.

Asia-Pacific revenue more than doubles, Europe grows nearly 30%

European revenue rose nearly 30% year-on-year in the period. Asia-Pacific revenue grew by more than 100% in Q1–Q3 2026, with progress in Singapore, Japan, South Korea, Australia and New Zealand.

MADRID – October 29, 2026 -- Hengrui Pharma presented a record 64 oncology studies at the ESMO Congress 2026 in Madrid. Innovative oncology medicines generated 81.02% of the company's innovative medicine sales revenue in 2025.

Hengrui lists 64 accepted studies across 21 drugs

The accepted work comprises three Proffered Papers, three Rapid Oral presentations, 32 Posters and 26 e-Posters. The studies span more than ten cancer areas, including gastrointestinal, lung, breast, gynecological and genitourinary cancers, plus supportive care. They involve 21 innovative drugs in China: nine approved products and 12 investigational candidates.

Hengrui has attended ESMO for 11 consecutive years since 2016. It has presented nearly 200 research findings at the congress since 2023.

United States – October 23, 2026 -- Procter & Gamble's Febreze Unstopables Touch Fabric Spray is the first P&G product to incorporate materials based on the company's space-based research, sponsored by the International Space Station (ISS) National Laboratory. P&G household products are used every day by more than 4 billion people worldwide, more than half the Earth's population.

Touch-activated scent release is the first commercial output of P&G's ISS work

The latest Febreze formulation features touch-activated scent release technology. It contains microscopic capsules of perfume suspended in a liquid that, according to P&G researcher Matt Lynch, looks and feels like water. The capsules release a small burst of fragrance when a hand is rubbed on a sprayed surface or someone walks over it, countering unpleasant odors.

Suzhou – October 19, 2026 -- MegaRobo Technologies has launched Poreva Open, a global AI protein design competition that will put more than 10,000 designs through standardized wet-lab experiments and offers US$250,000 in cash prizes.

Megalaxy Lab to run double-blind validation of every submission

Teams from academic institutions, research organizations, university laboratories, and biotech and AI companies can enter. Participants may use any models, algorithms or design methods. All submissions go through double-blind experimental evaluation at MegaRobo's Megalaxy Lab.

Results and experimental data, including data on unsuccessful designs, will be published after the competition. Publication is subject to intellectual property and compliance requirements.

Seoul – – October 07, 2026 -- Amorepacific secured two Top 10 Podium Award honors at the IFSCC Congress 2026 in Perth, Australia, for research applying deep learning and real-time sensing to skin aging prediction and sensory quantification.

Deep learning models predict heat-accelerated skin aging and ingredient efficacy

Researcher Eun-Jeong Choi of Amorepacific's R&I Center presented a study titled "Skin Aging in the Era of Global Boiling: Deep Learning-Guided Transcriptomic Signatures of Heat-Accelerated Aging," building on more than 20 years of heat-aging research. The work integrated transcriptomic analysis with deep learning to forecast skin aging progression, identify ingredients that restore age-related damage, and confirm their efficacy. The study was named a Top 10 Podium Fundamental Research Award honoree.

Valby – October 02, 2026 -- H. Lundbeck A/S will present late-breaking Phase III data on its multiple system atrophy (MSA) drug candidate amlenetug alongside new Parkinson's disease pipeline results at the International Congress of Parkinson's Disease and Movement Disorders (MDS) 2026 in Seoul, South Korea, running October 4-8.

MASCOT trial enrolled 401 participants across a global Phase III program

The late-breaking oral presentation will detail baseline characteristics of participants in MASCOT (NCT06706622), Lundbeck's ongoing Phase III trial of amlenetug in MSA. The trial enrolled 401 participants with clinically probable or established MSA, covering both MSA-C and MSA-P subtypes, across sites in North America, Europe, Asia and Australia. The double-blind treatment period runs 72 weeks, comparing high- and low-dose amlenetug against placebo, with results expected in Q3 2027.

Perth – September 28, 2026 -- PECHOIN, a Chinese skincare brand, is marking its 10th consecutive year of participation at the Congress of the International Federation of Societies of Cosmetic Chemists (IFSCC), presenting new research on Asian skin at what is widely regarded as the cosmetics industry's top scientific forum.

PECHOIN has won seven IFSCC international scientific awards over nine years

The brand became the first IFSCC Gold Member in China and has been recognized three times as the only Gold-level partner in Asia. Over the past decade, PECHOIN has submitted nearly 200 research papers to IFSCC Congresses, with close to 100 accepted. It is also the first Chinese brand to receive the IFSCC Young Scientist Award, doing so three times.

Dallas – September 18, 2026 -- Scottish Rite for Children has been ranked No. 1 in the nation for pediatric orthopedic care by U.S. News & World Report's 2026-2027 Best Children's Hospitals rankings, marking the first time the institution has secured the top spot for two consecutive years.

Rankings draw on data from 114 hospitals nationwide

U.S. News develops the annual rankings in partnership with RTI International, which collected and analyzed data from 114 children's hospitals and surveyed thousands of pediatric specialists. Evaluation criteria include clinical outcomes, compliance with established best practices, and the level and quality of hospital resources tied directly to patient care. Scottish Rite has ranked among the nation's top pediatric orthopedic programs for nearly two decades, in collaboration with Children's Medical Center Dallas and UT Southwestern Medical Center.

Shanghai – September 18, 2026 -- MoleculeMind, an AI-native bioengineering infrastructure company, has had research on its reactive atomistic modeling platform QuantaMind published in Science Advances, demonstrating Density Functional Theory (DFT)-level accuracy in simulating 10,000-atom biomolecular systems over tens-of-nanosecond timescales.

QuantaMind becomes first platform to simulate a complete enzyme reaction cycle

The study shows QuantaMind enabling AI to observe the full atomic-scale process of proton transfer, bond breaking and formation, and complete enzyme catalytic cycles. In industrial deployments, the platform has been scaled further to model reactive systems comprising hundreds of thousands of atoms.

Baltimore – September 16, 2026 -- Morgan State University has secured high-performance GPU compute resources through a new collaboration with Google Public Sector, aiming to reach Carnegie R1 research classification and establish a national blueprint for HBCU digital transformation.

Google's Program for Accelerated Research grants Morgan State advanced GPU infrastructure

The partnership, formed through Google Public Sector's Program for Accelerated Research (GPAR), gives Morgan State faculty and students access to high-performance computing for work in AI, cybersecurity, climate science and health sciences. The university is targeting Carnegie R1 status, the top classification for "very high research activity," which would unlock additional federal funding and attract research talent.